LU86403A1 - 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers - Google Patents

5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers Download PDF

Info

Publication number
LU86403A1
LU86403A1 LU86403A LU86403A LU86403A1 LU 86403 A1 LU86403 A1 LU 86403A1 LU 86403 A LU86403 A LU 86403A LU 86403 A LU86403 A LU 86403A LU 86403 A1 LU86403 A1 LU 86403A1
Authority
LU
Luxembourg
Prior art keywords
pyrimidine
carboxamide
hydrogen atom
hydroxy
dihydro
Prior art date
Application number
LU86403A
Other languages
English (en)
French (fr)
Inventor
Arthur D Brewer
Original Assignee
Uniroyal Chem Co Inc
Minatelli John A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chem Co Inc, Minatelli John A filed Critical Uniroyal Chem Co Inc
Publication of LU86403A1 publication Critical patent/LU86403A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU86403A 1985-04-22 1986-04-22 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers LU86403A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/725,736 US4636508A (en) 1985-04-22 1985-04-22 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US72573685 1985-04-22

Publications (1)

Publication Number Publication Date
LU86403A1 true LU86403A1 (fr) 1987-12-07

Family

ID=24915762

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86403A LU86403A1 (fr) 1985-04-22 1986-04-22 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers

Country Status (21)

Country Link
US (1) US4636508A (de)
JP (1) JPS6259264A (de)
CN (2) CN1014990B (de)
AT (1) AT391864B (de)
AU (3) AU592559B2 (de)
BE (1) BE904641A (de)
CA (1) CA1274509A (de)
CH (1) CH668970A5 (de)
DE (1) DE3613447A1 (de)
DK (1) DK182986A (de)
ES (3) ES8800671A1 (de)
FR (1) FR2580642B1 (de)
GB (1) GB2174391B (de)
GR (1) GR861024B (de)
IL (2) IL78576A0 (de)
IT (1) IT1214499B (de)
LU (1) LU86403A1 (de)
NL (1) NL8601023A (de)
NZ (1) NZ215874A (de)
SE (1) SE8601826L (de)
ZA (1) ZA862630B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
FR2628869A1 (de) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd
FR2628741A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd Nouveaux composes n-phenyl-5-pyrimidinecarboxamides et composition pharmaceutique les contenant utilisable pour induire la regression de la leucemie ou des tumeurs
EP0430885A3 (en) * 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
WO2003035076A1 (en) * 2001-10-26 2003-05-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
US9428466B2 (en) * 2013-11-13 2016-08-30 Raymond P. Warrell, Jr. Methods for reducing uric acid levels using barbiturate derivatives
WO2015123003A1 (en) * 2014-02-14 2015-08-20 Warrell Raymond P Bifunctional compounds and use for reducing uric acid levels
WO2016118611A1 (en) 2015-01-22 2016-07-28 Warrell Raymond P Jr Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
ES2925186T3 (es) 2016-07-06 2022-10-14 Acquist Llc Compuestos y su uso para reducir los niveles de ácido úrico
WO2018200571A1 (en) 2017-04-25 2018-11-01 Arbutus Biopharma Corporation Substituted 2,3-dihydro-1h-indene analogs and methods using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670756A1 (de) * 1966-10-05 1970-12-23 Hoechst Ag Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
NZ183999A (en) * 1976-05-06 1978-09-20 Ciba Geigy Ag 5-phenylcarbamoyl-barbituric acid derivatives and insecticidal agents
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5625166A (en) * 1979-08-09 1981-03-10 Banyu Pharmaceut Co Ltd 5-fluorouracil derivative
JPS5843960A (ja) * 1981-09-10 1983-03-14 Shoichiro Ozaki ５−フルオロウラシル誘導体，その製造法および制ガン剤
DE3347795A1 (de) * 1983-01-14 1985-08-01 Ozaki, Shoichiro, Ehime Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind
JPS6012322A (ja) * 1983-07-01 1985-01-22 Toyota Motor Corp 四リンク型サスペンシヨン
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GR861024B (en) 1986-08-14
IL78576A0 (en) 1986-08-31
SE8601826D0 (sv) 1986-04-21
DE3613447A1 (de) 1986-10-30
IT8620153A0 (it) 1986-04-18
NL8601023A (nl) 1986-11-17
CN86102767A (zh) 1987-01-07
CA1274509A (en) 1990-09-25
CH668970A5 (de) 1989-02-15
AT391864B (de) 1990-12-10
BE904641A (fr) 1986-10-21
ES8801220A1 (es) 1988-01-01
DK182986A (da) 1986-10-23
ES557684A0 (es) 1988-01-01
GB2174391A (en) 1986-11-05
NZ215874A (en) 1988-09-29
AU5641886A (en) 1986-10-30
IL86711A0 (en) 1988-11-30
US4636508A (en) 1987-01-13
DE3613447C2 (de) 1991-04-11
ES554245A0 (es) 1987-11-16
CN1014990B (zh) 1991-12-04
GB2174391B (en) 1988-12-29
ATA101986A (de) 1990-06-15
DK182986D0 (da) 1986-04-21
CN1038450A (zh) 1990-01-03
FR2580642B1 (fr) 1988-12-30
ZA862630B (en) 1986-11-26
ES8800671A1 (es) 1987-11-16
AU2219588A (en) 1989-01-05
AU592559B2 (en) 1990-01-18
IT1214499B (it) 1990-01-18
GB8609244D0 (en) 1986-05-21
ES557683A0 (es) 1987-12-16
ES8801219A1 (es) 1987-12-16
FR2580642A1 (fr) 1986-10-24
SE8601826L (sv) 1986-10-23
JPS6259264A (ja) 1987-03-14
AU2219688A (en) 1989-01-05

Similar Documents

Publication Publication Date Title
FR2577551A1 (fr) Derives de benzoyl uree, procede pour les preparer, et compositions antitumorales les contenant
LU86403A1 (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
EP1001944B1 (de) Pyrazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0113330B1 (de) Acylierte Enamidverbindungen, diese enthaltende pharmazeutische Zusammensetzungen und Verwendung dieser Verbindungen
WO1991002725A1 (fr) Derives de la 5-amino-1,2,3,4-tetrahydro-acridine et applications comme medicaments
FR2620450A1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
LU83713A1 (fr) Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant
BE1001262A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
BE1001263A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
EP0087337A1 (de) 2-Piperazinyl-4-phenyl-quinazolin-Derivate mit antidepressiven Eigenschaften, Verfahren zu deren Herstellung und diese enthaltende Arzneimitteln
LU87152A1 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines,de meme que le traitement de la leucemie et des tumeurs avec ces substances
EP0187096A1 (de) Arylalcoyloxymethyl-2-morpholine, deren Herstellung und deren Verwendung als Arzneimittel für die Behandlung von Zentralnervensystemstörungen
EP1007522B1 (de) 2- 4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung
LU87274A1 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes
LU87275A1 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes
NO159588B (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 5-okso-2-pyrrolidin-propansyrederivater.
FR2465716A1 (fr) 1-(alkyle ramifie)-3-(2-haloethyl)-3-nitroso-urees utilisables comme agents antitumoraux
JPS6377818A (ja) ５−〔１−ヒドロキシ−２−（イソプロビルアミノ）エチル〕アントラニロニトリルを用いる糖尿病の治療薬
FR2516085A1 (fr) Sels quaternaires de n,n3-di(b-bromopropionyl)-n1,n2-dispirotripiperazinium, procede de preparation desdits sels et medicament a action antitumorale a base d'un tel sel
FR2481281A1 (fr) Derives de la nonaprenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits
CA2968483A1 (fr) Derives hydroxybisphosphoniques hydrosolubles de la doxorubicine
CH622023A5 (en) Process for the preparation of a water-soluble compound based on a substituted phenylaminoalcohol
EP0022737B1 (de) Als Arzneimittel verwendbare Iminderivate von 5-Amino-1,3-benzodioxol und ihre Herstellung
EP0194164A2 (de) N-Carboxyalcoyl-2-oxo-3-diaryl-5-6 Triazine als Heilmittel